Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Thank you

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Feb 01, 2021 2:23pm

120 Views

Post# 32438484

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Thank you

Great we want proactive company we need to be proactive too I have sent many emails to IR too and don't care if she refuses to respond."bugging Theratechnologies mode".

Bucknelly21 wrote:
sent this to Phillipe

You guys have not participated in the bubble beside from taking easy money in what appears to be a really bad deal for long term shareholders and a great deal for banks who appear to keeping the market warrants and selling everything else. I hope I’m wrong. I hate to say it but it’s true, no real value for shareholders other that hope one of the things in the pipeline works out. The playing everything close to the chest strategy has not worked when luc was there and is not working now. Try mixing it up a little, it certainly can’t hurt the markets view of the company because it appears the market doesn’t buy into anything that’s happening behind the closed doors.

Sent from my iPhone